The evaluation of research tools inventions patentability in nanobiotechnology

Journal of Bionanoscience

Volumn 6, Issue 2, 2012, Pages 113-126

  Ahmadi, Maryam ^a   Ahmadi, Leila ^b   Koosha, Abutaleb ^c  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c University of Judicial Sciences and Administrative Services   (Iran)

Author keywords

EPC; Intellectual property rights; Nanobiotechnology; Patent; Research tools

Indexed keywords

ACCESS TO RESEARCH; COMMERCIAL ENTERPRISE; EPC; INTELLECTUAL PROPERTY RIGHTS; KEY TECHNOLOGIES; LIFE-SCIENCES; PATENT; PATENTABILITY; RESEARCH AND DEVELOPMENT; RESEARCH TOOLS;

GENES; NANOBIOTECHNOLOGY; RESEARCH;

PATENTS AND INVENTIONS;

EID: 84869200100     PISSN: 15577910     EISSN: 15577929     Source Type: Journal    
DOI: 10.1166/jbns.2012.1075     Document Type: Article

References (54)

1. S. Farnley, P. Morey-Nase, and D. Sternfeld, Current Opinion in Biotechnology 15, 254 (2004), www.sciencedirect.com.
2. "Patents: Frequently Asked Questions", World Intellectual Property Organization. http://www.wipo.int/patentscope/en/patents-faq.html# protection, (Retrieved 22 February 2009).
3. Human Genome Project Information, About the Human Genome Project, http://www.ornl.gov/sci/techresources/Human-Genome/project/about.shtml.
4. N. S. Mueller, Should Research Tools Be Patentable? Troubles and Chances of Patenting Research Tools in Biotechnology and Nanotechnology, August 31 (2008). Available at SSRN: http://ssrn.com/abstract=1265731 or http://dx.doi.org/10.2139/ssrn.1265731.
5. L. Wang, A. Brock, B. Herberich, and P. G. Schultz, Science 292, 498 (2001).
6. V. Döring, H. D. Mootz, L. A. Nangle, T. L. Hendrickson, V. de Crécy-Lagard, P. Schimmel, and P. Marlière, Science 292, 501 (2001).
7. J. Trent, Nanotechnology R&D, at http://ipt.arc.nasa. gov/trent.html.
8. C. A. Mirkin, K.-B. Lee, S.-J. Park, J. C. Smith, and M. Mrksich, Science 295, 1702 (2002).
9. A. Higgins and S. H. Koucky, Machine Design 75, 47 (2003).
10. Q. Wang, T. Lin, L. Tang, J. E. Johnson, and M. G. Finn, Chem. Int. Ed. 41, 459 (2002).
11. National Institute for Nanotechnology, University of Alberta, Canada, Nanobiotechnology, ppt no. 3, http://www.orion.on.ca/events/summits/2005ppt/ petersen.ppt.
12. S. Jackson, M. Rapoza, R. Juliano, K. Gonsalves, and K. Tindall, Nanobiotechnology, Biotechnology Works in North Carolina (2007).
13. B. M. Prasanna, Nanotechnology in agriculture, www.iasri.res.in/./10- nanotech-in-Agriculture-BM-Prasanna-1.
14. Australian Government, Australian Law Reform Commission, Genes and Ingenuity: Gene patenting and human health (ALRC Report 99)/12. Patents and Human Genetic Research -Patents and research tools, http://www.alrc.gov.au/ publications/12-patents-andhuman-genetic-research/patents-and-research-tools#- ftn38.
15. National Institutes of Health Working Group on Research Tools, Report of the National Institutes of Health (NIH) Working Group on Research Tools (1998), http://www.nih.gov/news/researchtools/index.htm#backgrnd;
16. Appendix B, http://www.nih.gov/news/researchtools/appendb.htm.
17. Waldeck, Research Tool Patents after Integra v. Merck -Have they reached a Safe Harbor? (2008), pp. 380.
18. J. Pénin and J. P. Wack, Research Tool Patents and Free-Libre Biotechnology: A Unified Perspective, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg in its series Working Papers of BETA with number (2007), pp. 4.
19. M. A. Lemley, Stanford Law Review 58, 601 (2005).
20. Cohen, S. N. Chang, A. C. Y. Boyer, W. H. Helling, and B. Robert, Construction of Biologically Functional Bacterial Plasmids In Vitro, Proceedings of the National Academy of Sciences of the USA (1973), Vol. 70, pp. 3240-3244, http://www.pubmedcentral. nih.gov/picrender.fcgi?artid=427208 and blobtype=pdf.
21. The Nobel Prize in Chemistry 1993, Polymerase Chain Reaction, http://nobelprize.org/nobel-prizes/chemistry/laureates/1993/illpres/pcr.htm1.
22. Diamond V. Chakrabarty, 447 U.S. 303, 206 USPQ 193 (1980).
23. C. Clift, Patenting and Licensing Research Tools, Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (eds.), A. Krattiger, R. T. Mahoney, and L. Nelsen, et al., MIHR: Oxford, U.K., and PIPRA: Davis, USA (2007), Available online at www.ipHandbook.org.
24. Nanowerk, Growing Nanotechnology Problems: Navigating the Patent Labyrinth (2007), http://www.nanowerk.com/spotlight/spotid =1367.php.
25. Proceedings of the National Academy of Sciences of the U.S., PNAS, DNA-Nanotube-Induced Alignment of Membrane Proteins for NMR Structure Determination (2007).
26. WIPO, http://www.wipo.int/pctdb/en/wo.jsp?IA=WO2006122175 and DISPLAY=STATUS.
27. Chemical and Engineering News, DNA Nanotubes (2005), http://pubs.acs.org/ cen/news/83/i23/8323notw8.html.
28. EETIMES deutschland, Nanotube-Prozesse: Feintuning für kommerzielle Applikationen, August 2004, http://www.eetimes.eu/germany/46802592.
29. L. M. U. Munich, Nano-Heizplatten Für DNA (2008), http://www.physik.uni-muenchen.de/aus-der-fakultaet/fak-nachrich ten/forschung/heizplatten-nim-08.html, http://pubs.acs.org/cgi-bin/abstract. cgi/nalefd/2008/8/i02/abs/nl073028i.html.
30. Hoffmann, A Modest Proposal: Toward Improved Access to Biotechnology Research Tools By Implementing a Broad Experimental Use Exception (2004), pp. 1021.
31. G. V. Overwalle, 2007, Gene Patents and Public Health. Katholieke Universiteit Leuven/Katholieke Universiteite Brussel: CIR -Centrum for Intellectual Property Rights, Series on Intellectual Property Law. No. 21. Brussels: Bruylant.(Simon in Overwalle, Gene Patents and Public Health (2007), p. 117.
32. Waldeck, Research Tool Patents after Integra V. Merck -Have they reached a Safe Harbor? (2008), pp. 385-386.
33. J. Hope, Biobazaar -The Open Source Revolution and Biotechnology, Cambridge/Massachusetts/London (England): Harvard University Press (2008), p. 90.
34. M. Heller and R. Eisenberg, Science 280, 698 (1998).
35. J. P. Walsch, A. Arora, and W. M. Cohen, Effects of research tool patents and licensing on biomedical innovation, Patents in the Knowledge-based Economy, edited by W. N. Cohen, S. Merrill, National Academies Press, Washington DC (2003), pp. 285-340.
36. N. Thumm, Technovation 25, 1410 (2005).
37. C. Shapiro: Navigating the patent thicket: Cross licenses, patent pools, and standard-setting, Competition Policy Center Working Paper Series CPC00-011, UC Berkeley (2000).
38. Hacon, R. Pagenberg, and Jochen, Concise European Patent Law, Alphen aan den Rijn: Kluwer Law International (2007).
39. Tritton, Intellectual Property in Europe, Tritton, Guy. Intellectual Property in Europe, 3rd edn. Sweet and Maxwell Ltd, London (England) (2008), pp. 128.
40. Nuffield Council in Bioethics, The Ethics of Patenting DNA, A Discussion Paper (2002), http://www.nuffieldbioethics.org/fileLibrary/pdf/the ethics of patentingdna.pdf.
41. Jaffe, A. B. Lerner, and Josh, Innovation and its Discontents -How our broken patent system is endangering innovation and progress, and what to do about it, Princeton University Press, New Jersey (U.S.)/Oxfordshire (England) (2004).
42. The Human Genome Project and Patenting DNA Sequences (1994), Office of Technology Assessment, U.S. Congress.
43. Patents and Innovation: Trends and Policy Challenges© OECD Applications for permission to reproduce or translate all or part of this material should be made to: OECD Publications, 2 rue André-Pascal, 75775 Paris Cedex 16, France (2004).
44. Nanowerk, Nanotechnology and Intellectual Property Issues (2006), http://www.nanowerk.com/news/newsid=1187.php.
45. G. I. Zekos, Nanotechnology and Biotechnology Patents, International Journal of Law and Information Technology, Oxford University Press (2006), Vol. 14, No. 3, pp. 310-369. SSRN: http://papers.ssrn.com/sol3/papers.cfm?abstract- id=1098662.
46. M. Lemley, Patenting Nanotechnology, Zekos, Nanotechnology and Biotechnology Patents, p. 363.
47. The Royalty Society and The Royal Academy of Engineering, Nanoscience and Nanotechnologies: Opportunities and Uncertainties (2004), pp. 19-20, No. 77. http://www.nanotec. org.uk/report/Nano%20report%202004%20fin.pdf.
48. Nanowerk, Nanotechnology Patents and The Future of the Pharma Industry (2007), http://www.nanowerk.com/spotlight/spotid=2912. php.
49. MedicalDeviceLink, Navigating the Nanotechnology Patent Thicket (2007), http://www.devicelink.com/mddi/archive/07/11/008.html.
50. Wissenschaft.de, Erstes Pflanzen-Genom entschlüsselt (2000), http://www.wissenschaft.de/wissenschaft/news/155717.html.
51. Human Genome Sequencing Center at Baylor College of Medicine, Honey Bee Genome Project, http://www.hgsc.bcm.tmc.edu/projects/honeybee/.
52. Greenpeace, Die wahren Kosten der Gen-Patente (2004), p. 9.
53. Heise Online, Genetische Eigentumsverhältnisse (2005), http://www. heise.de/tp/r4/artikel/21/21148/1.html.
54. E. R. Gold, Y. Joly, and T. Caulfield, Genetic Research Tool, The Research Exception and Open Science, GenEdit (2005), Vol. 3, pp. 1-13, www. humgen.org/genedit.